Beskrivelse af patientkortet og dets nødvendighed Bortskaffelse af uønsket medicin Nationale eller andre specifikke foranstaltninger, der finder anvendelse, for at en recept på Revlimid, kan blive udleveret
3 All patient brochures should contain the following elements: • That lenalidomide is teratogenic in animals and is expected to be teratogenic in humans. • That Revlimid may cause neutropenia and thrombocytopenia and the need for regular blood tests • Description of the patient card and its necessity • Disposal of unwanted medicine • National or other applicable specific arrangements for a prescription for Revlimid to be dispensed • That the patient should not give Revlimid to any other person • That the patient should not donate blood • That the patient should tell their doctor about any adverse events